3 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Endocrine Gland Neoplasm: new trials by email Literature Review of Endocrine Gland Neoplasm trials Research Report on Endocrine Gland Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. Pancreatic Neoplasm, Digestive System Neoplasm | Recruiting | OncoSil Medical Limited | 500 | 2022-04-12 | 2024-04-30 | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer Ocoxin-Viusid - Carcinoma, Ovarian Neoplasm | Phase 2 | Completed | Catalysis SL | 40 | 2018-10-25 | 2022-07-06 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors pralsetinib (BLU-667) - RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 590 | 2017-03-17 | 2025-05-31 |
| Assessing the Patient Experience in Cancer Care Brain Neoplasm, Breast Neoplasm | Completed | Mayo Clinic | 408 | 2012-05-01 | 2016-01-20 |
Endocrine Gland Neoplasms (4) · Endocrine System Diseases (3) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Lung Neoplasms (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Neoplasms (2) · Adenocarcinoma (1) · Adenocarcinoma, Papillary (1)
Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Brain Diseases (1) · Breast Diseases (1) · Bronchial Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1)
Ocoxin (1) · pralsetinib (1)
Catalysis SL (1) · Hoffmann-La Roche (1) · Mayo Clinic (1) · OncoSil Medical Limited (1)
Spain (2) · United Kingdom (2) · United States (2) · Belgium (1) · China (1) · Cuba (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Jon C Tilburt, MD, MPH (1) · Paul J Ross, MRCP, MBBS (1)
PMID 34118197, PMID 34118198, PMID 35715405, PMID 35962206, PMID 37282666, PMID 37916501, PMID 37934000, PMID 38009200, PMID 40639400, PMID 41886723
2016 (1), R01AT006515 (1)